Skip to main content

Profile hero

Profile details

About Dr. Maximilian Zellerhoff

Maximilian is a member of our intellectual property and information technology practice within our global transactions group. 

Maximilian is involved in cross-border corporate transactions and carve-out projects and advises on complex contract negotiation and drafting.

He speaks English and German.

Recent work

  • Life Sciences & Healthcare
    • Eppendorf on the sale of its micro manipulation product portfolio to Calibre Scientific
    • Grünenthal on a joint venture collaboration with Kyowa Kirin International, the Japan-based global specialty pharmaceutical company, in relation to Kyowa Kirin's established drug portfolio of 13 brands across six therapeutic areas with a focus on pain management
    • International Chemical Investors Group (ICIG) on their sale of CordenPharma, a leading global contract development & manufacturing organization (CDMO), to European private equity firm Astorg
    • International chemicals company LANXESS on its $1,3bn acquisition of the Microbial Control business of International Flavors & Fragrances (IFF)
    • Grünenthal on its acquisition of the men's health product Nebido for a purchase price of up to € 500m from Bayer AG
    • Grünenthal on its acquisition of Mestex AG
    • International pharmaceutical and biotechnology company AstraZeneca on its $39bn acquisition of Alexion Pharmaceuticals
    • International chemicals company LANXESS on its acquisition of Theseo Group, a manufacturer of disinfectant and hygiene solutions
    • Private equity investor Charterhouse Capital Partners / SERB on the $800m acquisition of the BTG Specialty Pharmaceuticals business from Boston Scientific Corporation
  • Technology
    • Accenture on the acquisition of Sentia Group's business in the Netherlands, Bulgaria and Belgium. The Sentia Group provides cloud advisory and delivery services
    • Private equity investor EQT on the sale of Utimaco Verwaltungs GmbH, one of the leading global providers of mission-critical professional cybersecurity and data intelligence solutions for regulated critical infrastructures
    • Private equity investor Francisco Partners on the acquisition of a majority of the shares in Native Instruments Holding GmbH, the Berlin-based global leader in digital music creation software and hardware
  • Other
    • Schenck Process Group on the $730M sale of its Food and Performance Materials Business to Hillenbrand
    • Röhm on the acquisition of SABIC's worldwide polycarbonate business
    • Prettl Group and private equity investor Trilantic Europe on the sale of Prettl SWH Group, a developer and manufacturer of sensor, connectivity and electrification solutions for the automotive industry, to Foxconn Interconnect Technology
    • Viridium on the acquisition of an extensive portfolio of traditional life insurance policies with approximately 720,000 insurance contracts and assets under management of approximately €21 billion from Zurich Group Germany
    • Continental, a leading automotive manufacturing company, on the carve-out of its powertrain business ("Vitesco Technologies")
    • Merck KGaA on the restructuring and repositioning of its Gernsheim production site
    • Global investment banking firm Goldman Sachs on its acquisition of Oikos Group, one of Europe's leading providers of prefabricated houses


  • Bucerius Law School, Hamburg, Germany (LL.B., First State Exam, Dr. iur.)
  • Emory University School of Law, Atlanta, GA
  • Hanseatic Higher Regional Court, Hamburg, Germany (Legal Traineeship (Referendariat) and Second State Exam)
  • Rechtsanwalt, Germany


  • Nomos; Studien zum Wirtschaftsstrafrecht - Neue Folge; 2020 Unbestimmte Scheinselbständigkeit - Das Arbeitgebermerkmal des § 266a StGB auf dem Prüfstand des Art. 103 II GG